Readers discuss an essay about whether it is a disease and how it should be diagnosed. Also: Fear in schools; natural ...

A clear FDA public education campaign could help shoppers make healthier choices. But it should first pay attention to the ...

Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...

Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

Obesity—the bad word everyone throws around, but few want to truly understand. The American Academy of Pediatricians thought ...

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.

At least 1 in 5 adults in each U.S. state live with obesity, new data from the Centers for Disease Control and Prevention ...

September marks National Childhood Obesity Awareness Month in the U.S., addressing the health issue that affects 1 in 5 ...

More than a quarter of Year 6 school pupils in a borough are obese according to a new report, with the rate more than ...

Analyst Michael Ulz of Morgan Stanley maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), retaining the price target ...

At a global level, Asia has almost half of all overweight children under five, while Africa has one-quarter of such children.

Roche focuses on obesity drug development, fast-tracking its CT-388 candidate, and targeting $3.6 billion in annual sales.